CSPC Innovation Pharmaceutical Hits Day Low Amid Price Pressure at CNY 41.18

CSPC Innovation Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.44% on August 13, 2026. The stock reached an intraday low of CNY 41.18, reflecting ongoing challenges within the company. Despite a positive performance over the past week, where it gained 3.2%, CSPC Innovation has struggled significantly over the past year, with a decline of 22.11%. This contrasts sharply with the China Shanghai Composite, which has seen a gain of 6.61% during the same period. Key financial metrics indicate a concerning trend for CSPC Innovation. The company has reported negative results for the last ten consecutive quarters, with a return on capital employed (ROCE) at a low of -9.81%. Additionally, the inventory turnover ratio stands at just 3.51 times, suggesting inefficiencies in managing stock. With a market capitalization of CNY 57,279 million, CSPC Innovation operates in the FMCG sector but has faced challenges in profitability, as evidenced by a net profit of CNY -95.43 million, which has fallen by 47.33%. The stock's performance continues to raise questions about its market position and operational effectiveness.